½ÃÀ庸°í¼­
»óǰÄÚµå
1818027

¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× ¿ø°ÝÄ¡·á ½ÃÀå ¿¹Ãø(-2032³â) : ÄÄÆ÷³ÍÆ®º°, Á¦°ø Çüź°, Àü°³ ¸ðµ¨º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®

Telehealth & Telemedicine Market Forecasts to 2032 - Global Analysis By Component (Hardware, Software and Services), Mode of Delivery, Deployment Model, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ ÀÇÇϸé, ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× ¿ø°ÝÄ¡·á ½ÃÀåÀº 2025³â¿¡ 1,077¾ï 2,000¸¸ ´Þ·¯, 2032³â¿¡´Â 2,613¾ï 8,000¸¸ ´Þ·¯¿¡ À̸£°í, ¿¹Ãø ±â°£ Áß ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 13.5%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.

¿ø°ÝÀÇ·á¿Í ¿ø°ÝÀÇ·á´Â ¿ø°ÝÁö¿¡¼­ ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇÑ µðÁöÅÐ Åë½Å ±â¼úÀÇ »ç¿ëÀ» ÀǹÌÇÕ´Ï´Ù. ¿ø°Ý ÀÇ·á´Â ÀÓ»ó Áø·á, °Ç°­ ±³À°, ¿ø°Ý ¸ð´ÏÅ͸µ, ȯÀÚ Âü¿© µî ±¤¹üÀ§ÇÑ È°µ¿À» Æ÷ÇÔÇϸç, ¿ø°Ý Ä¡·á´Â ƯÈ÷ °¡»ó Áø·á, Áø´Ü, Ä¡·á, ÈÄ¼Ó Ä¡·á µî ÀÓ»ó ¼­ºñ½º Á¦°ø¿¡ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. ÀÌ µÎ °¡Áö¸¦ °áÇÕÇϸé ȯÀÚ¿Í ÀÇ·áÁøÀÌ Á÷Á¢ ¸¸³ªÁö ¾Ê°íµµ È¿À²ÀûÀ¸·Î ±³·ùÇÏ°í °Ç°­À» °ü¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸¸¼ºÁúȯ Áõ°¡¿Í °í·ÉÈ­

°¡»ó Ç÷§ÆûÀº ¿ø°Ý ¸ð´ÏÅ͸µÀ» ÅëÇØ ´ç´¢º´, ½ÉÀ庴°ú °°Àº Áúº´À» °ü¸®Çϴµ¥ µµ¿òÀ» ÁÖ°í ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â µðÁöÅÐ µµ±¸¸¦ »ç¿ëÇÏ¿© º´¿ø ¹æ¹®À» ÁÙÀ̰í ȯÀÚ Âü¿©¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ¹× °¡Á¤¿ë ¼¾¼­°¡ ½Ç½Ã°£ °Ç°­ ÃßÀûÀ» °­È­ÇÕ´Ï´Ù. È®Àå °¡´ÉÇÑ Äɾ ´ëÇÑ ¼ö¿ä´Â ´Ù¾çÇÑ Áö¿ª¿¡ °ÉÃÄ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãß¼¼´Â Àå±âÀûÀÎ Áúº´ °ü¸®¿¡¼­ ¿ø°ÝÀÇ·áÀÇ ¿ªÇÒÀ» °­È­Çϰí ÀÖ½À´Ï´Ù.

ºÒÃæºÐÇÑ »óȯ ¹× ÁöºÒ ±¸Á¶

°¡»ó Áø·á´Â Á¾Á¾ ´ë¸é Áø·á¿Í µ¿µîÇÑ ¼öÁØÀÇ Áø·áºñ¸¦ û±¸ÇÏÁö ¸øÇÏ´Â °æ¿ì°¡ ÀÖ½À´Ï´Ù. º¸Çè Àû¿ë ¹× ÀÚ°Ý¿¡ °üÇÑ ±ÔÁ¤ÀÇ ºÒÈ®½Ç¼ºÀÌ °ø±ÞÀÚÀÇ Âü¿©¸¦ º¹ÀâÇÏ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù. ¼Ò±Ô¸ð Áø·á¼Ò¿¡¼­´Â ¿¹Ãø °¡´ÉÇÑ ¼öÀÍÀÌ ¾øÀ¸¸é ÅõÀÚ¿¡ ¾î·Á¿òÀ» °Þ½À´Ï´Ù. º¸Çè»çÀÇ ¿ø°ÝÁø·á º¸»ó Ç¥ÁØÈ­°¡ ´Ê¾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦µéÀº ÇコÄÉ¾î ½Ã½ºÅÛ¿¡ Æø³Ð°Ô ÅëÇյǴ °ÍÀ» ¹æÇØÇϰí ÀÖ½À´Ï´Ù.

Áö¿ø Á¤Ã¥ ¹× »óȯ ÇÁ·¹ÀÓ¿öÅ©

À¯¿¬ÇÑ Ã»±¸ ÄÚµå¿Í Á¦µµÀû Àμ¾Æ¼ºê°¡ µµÀÔÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±¹°¡ ÀÇ·á ½Ã½ºÅÛ°úÀÇ ÅëÇÕÀÌ º¸±ÞÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¼­ºñ½º Á¦°ø¾÷ü´Â ¼­ºñ½º¸¦ È®ÀåÇϰí, ¼­ºñ½º¸¦ ÃæºÐÈ÷ Á¦°ø¹ÞÁö ¸øÇÏ´Â »ç¶÷µé¿¡°Ô ¼­ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù. Ç¥ÁØÈ­µÈ °áÁ¦ ¸ðµ¨Àº ÀçÁ¤Àû Áö¼Ó°¡´É¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀÌ Àå±âÀûÀÎ ½ÃÀå ¼ºÀåÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù.

ÀÓ»óÀû ÇѰè¿Í µµÀÔ¿¡ ´ëÇÑ ÀúÇ×

½Åü °Ë»ç¿Í ½Ã¼úÀ» °¡»óÀ¸·Î ÀçÇöÇÏ´Â °ÍÀº ¾î·Æ½À´Ï´Ù. °í·ÉÀÚ³ª µðÁöÅÐ ¼­ºñ½º°¡ ÃæºÐÇÏÁö ¾ÊÀº Áý´ÜÀº Ç÷§Æû ÀÌ¿ëÀÌ ¾î·Á¿ï ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü´Â ¹ýÀû Ã¥ÀÓ°ú ¿öÅ©Ç÷οìÀÇ È¥¶õ¿¡ ´ëÇØ Á¶½É½º·´´Ù. ÀüÅëÀû Ä¡·á¿¡ ´ëÇÑ ¼±È£°¡ º¸±ÞÀ» ´ÊÃß°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ªÇаü°è°¡ º»°ÝÀûÀÎ µµÀÔ¿¡ À־ÀÇ °úÁ¦¸¦ ³º°í ÀÖ½À´Ï´Ù.

Äڷγª19ÀÇ ¿µÇâ

Äڷγª19 »çÅ´ Àü ¼¼°èÀûÀ¸·Î ¿ø°Ý ÀÇ·á¿Í ¿ø°Ý Ä¡·áÀÇ Ã¤ÅÃÀ» Å©°Ô °¡¼ÓÈ­Çß½À´Ï´Ù. ¹°¸®Àû À̵¿ÀÇ Á¦ÇÑ, »çȸÀû °Å¸®µÎ±â, º´¿ø ¹æ¹® Ƚ¼ö¸¦ ÁÙ¿©¾ß ÇÒ Çʿ伺À¸·Î ÀÎÇØ ÀÇ·áÁø°ú ȯÀÚµéÀº °¡»ó Áø·á¿¡ ÀÇÁ¸ÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¿ø°Ý ¸ð´ÏÅ͸µ, ¿Â¶óÀÎ Áø·á, µðÁöÅÐ °Ç°­ Ç÷§ÆûÀ» ÁÖ·ùÈ­ÇÏ¿© ÀÇ·á ¼­ºñ½º Á¦°øÀÇ ÇüŸ¦ º¯È­½ÃÄ×½À´Ï´Ù. ÀÌ À§±â´Â ¶ÇÇÑ ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø°ú »óȯÀÇ À¯¿¬¼ºÀ» ÃËÁøÇϰí ÀÇ·á ½Ã½ºÅÛ¿¡ ´ëÇÑ ºü¸¥ ÅëÇÕÀ» ÃËÁøÇß½À´Ï´Ù. ÆÒµ¥¹Í ÀÌÈÄ, ¿ø°ÝÀÇ·á´Â Áß¿äÇϰí Á¢±ÙÇϱ⠽¬¿î Ä¡·á ¼Ö·ç¼ÇÀ¸·Î °è¼Ó ÁøÈ­Çϰí ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ¼ÒÇÁÆ®¿þ¾î ºÎ¹®ÀÌ °¡Àå Ŭ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼ÒÇÁÆ®¿þ¾î ºÎ¹®Àº ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â °¡»ó ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. È­»óȸÀÇ, EHR ÅëÇÕ, AI ºÐ·ù µµ±¸°¡ ³Î¸® Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý Ç÷§ÆûÀº È®À强°ú ½Ç½Ã°£ ¾×¼¼½º¸¦ Á¦°øÇÕ´Ï´Ù. º¥´õµéÀº »ç¿ë ÆíÀǼº°ú º¸¾ÈÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ¸ð¹ÙÀϰú ¿þ¾î·¯ºíÀÇ ÅëÇÕÀº ±â´ÉÀ» È®ÀåÇϰí ÀÖ½À´Ï´Ù. ÀÌ ºÐ¾ß´Â ¾ÕÀ¸·Îµµ ¿ø°ÝÀÇ·á ¾÷¹«ÀÇ Áß½ÉÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ´Â Ȩ ÄÉ¾î ¼³Á¤ ºÎ¹®Àº ´ÙÀ½°ú °°½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ºÐ»êÇü Äɾ ´ëÇÑ ¼ö¿ä Áõ°¡·Î ÀÎÇØ ÀçÅà ÄÉ¾î ¼³Á¤ ºÎ¹®ÀÌ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿ø°ÝÀÇ·á´Â Áý¿¡¼­ ¿ø°ÝÁø·á¿Í ¸¸¼ºÁúȯ °ü¸®¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ½º¸¶Æ® ±â±â ¹× ¼¾¼­´Â Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» Áö¿øÇÕ´Ï´Ù. °í·ÉÈ­¿Í °Åµ¿ ºÒÆíÀ¸·Î ÀÎÇØ ÀçÅà °£È£ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. °ø±ÞÀÚ´Â º¹±¸ ¹× Àå±âÀûÀÎ Áö¿øÀ» À§ÇØ ¼­ºñ½º¸¦ ¸ÂÃãÈ­Çϰí ÀÖ½À´Ï´Ù. ÇコÄɾî´Â ÀçÅñٹ« ¸ðµ¨·Î ÀüȯÇϰí ÀÖÀ¸¸ç, ÀÌ ºÐ¾ß´Â ºü¸£°Ô ¼ºÀåÇÒ °ÍÀÔ´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ º¸±Þ°ú °­·ÂÇÑ ÇコÄɾî ÀÎÇÁ¶ó¿¡ ÈûÀÔ¾î °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. EHR/EMR ½Ã½ºÅÛ°úÀÇ ÅëÇÕ, °íµµÈ­µÈ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ, ¿ø°Ý »ó´ã ¼­ºñ½º°¡ ÁÖ¿ä Æ®·»µåÀÔ´Ï´Ù. ±ÔÁ¦Àû Áö¿ø°ú »óȯ ÇÁ·¹ÀÓ¿öÅ©°¡ ¿ø°ÝÀÇ·áÀÇ È®ÀåÀ» ÃËÁøÇϰí, ¸¸¼ºÁúȯÀÇ È®»êÀÌ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¼ÒÇÁÆ®¿þ¾î Ç÷§Æû°ú Ä¿³ØÆ¼µå ÀÇ·á±â±â°¡ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ±â¼ú Á¦°ø¾÷ü¿Í ÀÇ·á±â°üÀÇ ÆÄÆ®³Ê½ÊÀº AI ±â¹Ý Áø´Ü, ½Ç½Ã°£ ¿ø°Ý ¸ð´ÏÅ͸µ, µµ½Ã¿Í ³óÃÌÀ» ¾Æ¿ì¸£´Â ¿øÈ°ÇÑ È¯ÀÚ¿Í ÀÇ·áÁøÀÇ »óÈ£ÀÛ¿ë¿¡ ÃÊÁ¡À» ¸ÂÃß¾î Çõ½ÅÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª

¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀº µðÁöÅÐ ÀÎÇÁ¶ó °³¼±°ú ½º¸¶Æ®Æù º¸±Þ È®´ë·Î ÀÎÇØ °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. °¢±¹ Á¤ºÎ´Â ¿ø°ÝÀÇ·á Á¤Ã¥À» ÃßÁøÇϰí ÀÖÀ¸¸ç, ƯÈ÷ ¿ø°ÝÁö³ª ³óÃÌ Áö¿ªÀÇ ÀÇ·á ÆíÀǼºÀ» ³ôÀ̱â À§ÇØ ³ë·ÂÇϰí ÀÖ½À´Ï´Ù. ¸ð¹ÙÀÏ ±â¹Ý Ç÷§Æû, ¿ø°Ý »ó´ã ¼­ºñ½º, Àúºñ¿ë ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÌ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¹®È­Àû ¼ö¿ë, µðÁöÅÐ ÇコÄɾ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÇÏÀÌÅ×Å© ±â¾÷°ú º´¿øÀÇ Çù¾÷ÀÌ µµÀÔ¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ÀÎÅÍ³Ý ¿¬°áÀÇ ºÒ¾ÈÁ¤¼º, ±ÔÁ¦ÀÇ ´Ù¾ç¼º, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀº ±¹°¡º°·Î ´Ù¾çÇÑ ¼ö¿ä ÆÐÅÏÀ» º¸À̰í ÀÖÀ¸¸ç, È®À强°ú ´Ù±¹¾î Áö¿ø ¿ø°ÝÀÇ·á ¼Ö·ç¼ÇÀÌ Áß¿ä½ÃµÇ°í ÀÖ½À´Ï´Ù.

¹«·á Ä¿½ºÅ͸¶ÀÌ¡ ¼­ºñ½º

º» º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ ¼±ÅÃÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷¼Ò°³
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º È®Àο¡ µû¶ó ´Ù¸§)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç ÀÚ·á
    • 1Â÷ Á¶»ç ÀÚ·á
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå PorterÀÇ Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ¹ÙÀ̾îÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× ¿ø°ÝÄ¡·á ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • Çϵå¿þ¾î
    • ÀÇ·á ÁÖº¯±â±â
    • ¸ð´ÏÅÍ ¹× Áø´Ü ±â±â
    • ½º¸¶Æ®Æù
  • ¼ÒÇÁÆ®¿þ¾î
    • ¿ø°ÝÀÇ·á Ç÷§Æû
    • EHR/EMR ÅëÇÕ ¼Ö·ç¼Ç
    • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ¼ÒÇÁÆ®¿þ¾î
  • ¼­ºñ½º
    • ¿ø°Ý ÁøÂû ¼­ºñ½º
    • ¿ø°Ý ¸ð´ÏÅ͸µ ¼­ºñ½º
    • ¿ø°Ý ±³À°
    • ±â¼ú Áö¿ø

Á¦6Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× ¿ø°ÝÄ¡·á ½ÃÀå : Á¦°ø Çüź°

  • À¥ ±â¹Ý ¿ø°ÝÀÇ·á
  • Ŭ¶ó¿ìµå ±â¹Ý ¿ø°ÝÀÇ·á
  • On-Premise ¿ø°ÝÀÇ·á

Á¦7Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× ¿ø°ÝÄ¡·á ½ÃÀå : Àü°³ ¸ðµ¨º°

  • ½Ç½Ã°£(µ¿±â) ¿ø°ÝÀÇ·á
  • store and forward(ºñµ¿±â) ¿ø°ÝÀÇ·á
  • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM)

Á¦8Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× ¿ø°ÝÄ¡·á ½ÃÀå : ¿ëµµº°

  • ¿ø°Ý ¹æ»ç¼± Áø´Ü
  • ¿ø°Ý º´¸® Áø´Ü
  • ¿ø°Ý ÇǺΰú
  • ¿ø°Ý ½ÉÀ庴ÇÐ
  • ¿ø°Ý Á¤½ÅÀÇÇÐ ¹× Çൿ °Ç°­
  • ¿ø°Ý ¾È°ú
  • ¸¸¼ºÁúȯ °ü¸®
  • ÀÏ¹Ý ÁøÂû
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× ¿ø°ÝÄ¡·á ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • Ŭ¸®´Ð ¹× Àü¹®¼¾ÅÍ
  • °¡Á¤Ä¡·á ȯ°æ
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦10Àå ¼¼°èÀÇ ¿ø°ÝÀÇ·á ¹× ¿ø°ÝÄ¡·á ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷ ¹× ÇÕÀÛÅõÀÚ(JV)
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • Teladoc Health, Inc.
  • American Well Corporation
  • MDLIVE, Inc.
  • Doctor On Demand, Inc.
  • Babylon Health
  • HealthTap, Inc.
  • Livi(Kry International AB)
  • 1mg Technologies Pvt. Ltd.
  • Practo Technologies Pvt. Ltd.
  • Ping An Healthcare and Technology Company Limited
  • Alibaba Health Information Technology Limited
  • GlobalMed
  • MeMD, Inc.
  • eVisit, Inc.
  • Zipnosis, Inc.
LSH

According to Stratistics MRC, the Global Telehealth & Telemedicine Market is accounted for $107.72 billion in 2025 and is expected to reach $261.38 billion by 2032 growing at a CAGR of 13.5% during the forecast period. Telehealth and Telemedicine refer to the use of digital communication technologies to deliver healthcare services remotely. Telehealth encompasses a broad range of activities, including clinical care, health education, remote monitoring, and patient engagement, while telemedicine specifically focuses on providing clinical services such as virtual consultations, diagnosis, treatment, and follow-up care. Together, they enable patients and healthcare providers to interact and manage health efficiently without the need for in-person visits.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases & aging population

Virtual platforms are helping manage conditions like diabetes and heart disease through remote monitoring. Providers are using digital tools to reduce hospital visits and improve patient engagement. Wearables and home sensors are enhancing real-time health tracking. Demand for scalable care is growing across diverse geographies. These trends are reinforcing telehealth role in long-term disease management.

Restraint:

Inadequate reimbursement & payment structures

Virtual consultations often lack billing equivalence with in-person visits. Regulatory uncertainty around coverage and eligibility complicates provider participation. Smaller practices struggle to invest without predictable returns. Insurers are slow to standardize remote care reimbursement. These issues are limiting broader integration into healthcare systems.

Opportunity:

Supportive policies & reimbursement frameworks

Flexible billing codes and institutional incentives are promoting adoption. Integration with national health systems is accelerating deployment. Providers are expanding services to reach underserved populations. Standardized payment models are improving financial sustainability. These developments are enabling long-term market growth.

Threat:

Clinical limitations & adoption resistance

Physical exams and procedures are difficult to replicate virtually. Older adults and digitally underserved groups may struggle with platform use. Providers are cautious about liability and workflow disruption. Traditional care preferences are slowing uptake. These dynamics are creating challenges in full-scale adoption.

Covid-19 Impact:

The Covid-19 pandemic significantly accelerated the adoption of telehealth and telemedicine worldwide. Restrictions on physical movement, social distancing measures, and the need to reduce hospital visits drove healthcare providers and patients to rely on virtual consultations. It reshaped healthcare delivery by making remote monitoring, online consultations, and digital health platforms mainstream. The crisis also encouraged regulatory support and reimbursement flexibility, fostering rapid integration into healthcare systems. Post-pandemic, telehealth continues to evolve as a vital, accessible care solution.

The software segment is expected to be the largest during the forecast period

The software segment is expected to account for the largest market share during the forecast period due to its role in enabling virtual care delivery. Video conferencing, EHR integration, and AI triage tools are widely used. Cloud-based platforms offer scalability and real-time access. Vendors are improving usability and security. Mobile and wearable integration is expanding capabilities. This segment will remain central to telehealth operations.

The home care settings segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the home care settings segment is predicted to witness the highest growth rate due to growing demand for decentralized care. Telehealth enables remote consultations and chronic condition management at home. Smart devices and sensors support continuous monitoring. Aging populations and mobility issues are increasing in-home care needs. Providers are customizing services for recovery and long-term support. This segment is set for rapid growth as healthcare shifts toward home-based models.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by widespread adoption of digital health solutions and strong healthcare infrastructure. Integration with EHR/EMR systems, advanced remote patient monitoring, and teleconsultation services are key trends. Regulatory support and reimbursement frameworks encourage telehealth expansion, while increasing chronic disease prevalence fuels demand. The market is dominated by software platforms and connected medical devices. Partnerships between technology providers and healthcare institutions are accelerating innovation, focusing on AI-enabled diagnostics, real-time telemonitoring, and seamless patient-provider interactions across both urban and rural areas.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR by improving digital infrastructure and increasing smartphone penetration. Governments are promoting telemedicine policies to enhance healthcare accessibility, particularly in remote and rural areas. Market growth is driven by mobile-based platforms, teleconsultation services, and low-cost remote monitoring solutions. Cultural acceptance, rising awareness of digital healthcare, and collaborations between tech firms and hospitals are accelerating adoption. Challenges include inconsistent internet connectivity, regulatory variations, and data privacy concerns. The region shows diverse demand patterns across countries, emphasizing scalable and multilingual telehealth solutions.

Key players in the market

Some of the key players in Telehealth & Telemedicine Market include Teladoc Health, Inc., American Well Corporation, MDLIVE, Inc., Doctor On Demand, Inc., Babylon Health, HealthTap, Inc., Livi (Kry International AB), 1mg Technologies Pvt. Ltd., Practo Technologies Pvt. Ltd., Ping An Healthcare and Technology Company Limited, Alibaba Health Information Technology Limited, GlobalMed, MeMD, Inc., eVisit, Inc. and Zipnosis, Inc.

Key Developments:

In February 2025, American Well Corporation partnered with Vida Health to expand its clinical program portfolio, adding obesity and diabetes care-including GLP-1 therapies. This integration enhances Amwell's platform capabilities, allowing health plans to offer broader chronic care services through a unified digital experience.

In February 2025, Teladoc Health announced the acquisition of Catapult Health, a leader in virtual preventive care and at-home diagnostics. The deal strengthens Teladoc's integrated care strategy by enabling early detection, personalized health action plans, and direct enrollment into chronic condition programs like diabetes and hypertension.

Components Covered:

  • Hardware
  • Software
  • Services

Mode of Deliveries Covered:

  • Web-Based Telehealth
  • Cloud-Based Telehealth
  • On-Premises Telehealth

Deployment Models Covered:

  • Real-time (Synchronous) Telehealth
  • Store-and-Forward (Asynchronous) Telehealth
  • Remote Patient Monitoring (RPM)

Applications Covered:

  • Teleradiology
  • Telepathology
  • Teledermatology
  • Telecardiology
  • Telepsychiatry & Behavioral Health
  • Teleophthalmology
  • Chronic Disease Management
  • General Consultation
  • Other Applications

End Users Covered:

  • Hospitals
  • Clinics & Specialty Centers
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Telehealth & Telemedicine Market, By Component

  • 5.1 Introduction
  • 5.2 Hardware
    • 5.2.1 Medical Peripheral Devices
    • 5.2.2 Monitors & Diagnostic Equipment
    • 5.2.3 Smartphones
  • 5.3 Software
    • 5.3.1 Telehealth Platforms
    • 5.3.2 EHR/EMR Integration Solutions
    • 5.3.3 Remote Patient Monitoring Software
  • 5.4 Services
    • 5.4.1 Teleconsultation Services
    • 5.4.2 Telemonitoring Services
    • 5.4.3 Tele-education
    • 5.4.4 Technical Support

6 Global Telehealth & Telemedicine Market, By Mode of Delivery

  • 6.1 Introduction
  • 6.2 Web-Based Telehealth
  • 6.3 Cloud-Based Telehealth
  • 6.4 On-Premises Telehealth

7 Global Telehealth & Telemedicine Market, By Deployment Model

  • 7.1 Introduction
  • 7.2 Real-time (Synchronous) Telehealth
  • 7.3 Store-and-Forward (Asynchronous) Telehealth
  • 7.4 Remote Patient Monitoring (RPM)

8 Global Telehealth & Telemedicine Market, By Application

  • 8.1 Introduction
  • 8.2 Teleradiology
  • 8.3 Telepathology
  • 8.4 Teledermatology
  • 8.5 Telecardiology
  • 8.6 Telepsychiatry & Behavioral Health
  • 8.7 Teleophthalmology
  • 8.8 Chronic Disease Management
  • 8.9 General Consultation
  • 8.10 Other Applications

9 Global Telehealth & Telemedicine Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Clinics & Specialty Centers
  • 9.4 Home Care Settings
  • 9.5 Ambulatory Surgical Centers
  • 9.6 Other End Users

10 Global Telehealth & Telemedicine Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Teladoc Health, Inc.
  • 12.2 American Well Corporation
  • 12.3 MDLIVE, Inc.
  • 12.4 Doctor On Demand, Inc.
  • 12.5 Babylon Health
  • 12.6 HealthTap, Inc.
  • 12.7 Livi (Kry International AB)
  • 12.8 1mg Technologies Pvt. Ltd.
  • 12.9 Practo Technologies Pvt. Ltd.
  • 12.10 Ping An Healthcare and Technology Company Limited
  • 12.11 Alibaba Health Information Technology Limited
  • 12.12 GlobalMed
  • 12.13 MeMD, Inc.
  • 12.14 eVisit, Inc.
  • 12.15 Zipnosis, Inc.
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦